SERTRALINE HYDROCHLORIDE tablet, film coated États-Unis - anglais - NLM (National Library of Medicine)

sertraline hydrochloride tablet, film coated

direct rx - sertraline hydrochloride (unii: uti8907y6x) (sertraline - unii:quc7nx6wmb) - sertraline 50 mg - sertraline hydrochloride tablets are indicated for the treatment of the following [see clinical studies (14)]: major depressive disorder (mdd) obsessive-compulsive disorder (ocd) panic disorder (pd) posttraumatic stress disorder (ptsd) social anxiety disorder (sad) premenstrual dysphoric disorder (pmdd) sertraline hydrochloride tablets are contraindicated in patients: taking, or within 14 days of stopping, maois, (including the maois linezolid and intravenous methylene blue) because of an increased risk of serotonin syndrome [see warnings and precautions (5.2), drug interactions (7.1)]. taking pimozide [see drug interactions (7.1)]. with known hypersensitivity to sertraline (e.g., anaphylaxis, angioedema) [see adverse reactions (6.1, 6.2)]. 8.1 pregnancy risk summary overall, available published epidemiologic studies of pregnant women exposed to sertraline in the first trimester suggest no difference in major birth defect risk compared to the background rate for major b

Selegiline 10mg tablets Royaume-Uni - anglais - MHRA (Medicines & Healthcare Products Regulatory Agency)

selegiline 10mg tablets

a a h pharmaceuticals ltd - selegiline hydrochloride - oral tablet - 10mg

Selegiline 10mg tablets Royaume-Uni - anglais - MHRA (Medicines & Healthcare Products Regulatory Agency)

selegiline 10mg tablets

ivax pharmaceuticals uk ltd - selegiline hydrochloride - oral tablet - 10mg

Selegiline 10mg tablets Royaume-Uni - anglais - MHRA (Medicines & Healthcare Products Regulatory Agency)

selegiline 10mg tablets

alliance healthcare (distribution) ltd - selegiline hydrochloride - oral tablet - 10mg